Word

ESPERTI PHARMACEUTICALS

Status

Dead

Status Code

602

Status Date

Tuesday, May 16, 2023

Serial Number

90772225

Mark Type

4000

Filing Date

Monday, June 14, 2021

Abandoned Date

Wednesday, April 12, 2023

Trademark Owner History

Esperti Pharmaceuticals, LLC

Classifications

42 Consulting services in the field of pharmaceuticals and biotechnology research and development; consulting services for others in the field of design, planning, support and implementation of programs for scientific research of pharmaceuticals, laboratory testing of pharmaceuticals, diagnostics for pharmaceuticals, clinical trials of pharmaceuticals, testing, modeling and simulation of pharmaceuticals, and due diligence and audit of such programs; quality management services, namely quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical drug manufacturing and contract manufacturing; consulting pertaining to pharmacokinetics and biostatistics; conducting scientific feasibility studies

The English translation of ESPERTI in the mark is EXPERTS.
"PHARMACEUTICALS"

Trademark Events

May 16, 2023

Abandonment Notice E-Mailed - Failure To Respond

May 16, 2023

Abandonment Notice Mailed - Failure To Respond

May 16, 2023

Abandonment - Failure To Respond Or Late Response

Oct 11, 2022

Notification Of Non-Final Action E-Mailed

Oct 11, 2022

Non-Final Action E-Mailed

Oct 11, 2022

Non-Final Action Written

Sep 6, 2022

Assigned To Examiner

Sep 1, 2022

Teas/Email Correspondence Entered

Aug 31, 2022

Correspondence Received In Law Office

Aug 31, 2022

Teas Response To Office Action Received

Mar 5, 2022

Notification Of Non-Final Action E-Mailed

Mar 5, 2022

Non-Final Action E-Mailed

Mar 5, 2022

Non-Final Action Written

Mar 4, 2022

Assigned To Examiner

Sep 1, 2021

New Application Office Supplied Data Entered

Jun 17, 2021

New Application Entered